You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

SULFASALAZINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for sulfasalazine and what is the scope of patent protection?

Sulfasalazine is the generic ingredient in four branded drugs marketed by Pharmacia And Upjohn, Pfizer, Nuvo Pharms Inc, Watson Labs, Solvay, Chartwell, Epic Pharma Llc, Sun Pharm Industries, and Superpharm, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for sulfasalazine. Nine suppliers are listed for this compound.

Summary for SULFASALAZINE
Drug Prices for SULFASALAZINE

See drug prices for SULFASALAZINE

Drug Sales Revenue Trends for SULFASALAZINE

See drug sales revenues for SULFASALAZINE

Recent Clinical Trials for SULFASALAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 3
Cairo UniversityPhase 3
Rutgers, The State University of New JerseyPhase 2

See all SULFASALAZINE clinical trials

Pharmacology for SULFASALAZINE
Drug ClassAminosalicylate

US Patents and Regulatory Information for SULFASALAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs SULFASALAZINE sulfasalazine TABLET;ORAL 087197-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nuvo Pharms Inc SULFASALAZINE sulfasalazine TABLET;ORAL 040349-001 Jan 11, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Superpharm SULFASALAZINE sulfasalazine TABLET;ORAL 089339-001 Oct 26, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs SULFASALAZINE sulfasalazine TABLET;ORAL 085828-001 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.